Law School/Year: J.D., Notre Dame Law School, 1983
College/Year: B.B.A., University of Notre Dame, 1977
Jay de Groot has consummated more than $3 billion of merger and acquisition transactions across a wide range of industries and technologies. De Groot has also represented clients in a diverse array of securities offerings. He has helped raise more than $1 billion in initial public offerings.
De Groot regularly advises public companies on mergers and acquisitions, securities offerings, reporting and compliance, and corporate governance, and counsels a number of venture-backed and private equity-backed companies, as well as the funds that finance them. In the last several years, he has closed more than 60 venture capital financings with over $900 million of aggregate proceeds.
De Groot has more than 20 years of experience representing public and private companies, venture capital funds and underwriters in corporate and securities matters. In addition to his legal experience, de Groot has significant business experience, having served as senior vice president and general counsel of two publicly traded medical device and software companies, ALARIS Medical Systems and IVAC Medical Systems, where he was responsible for the corporate development, strategic planning and legal functions. ALARIS was a $600 million publicly traded company formed by the merger of IVAC Medical Systems and IMED, with 2,500 employees doing business in 120 countries. Prior to law school, de Groot was a Certified Public Accountant with KPMG.
De Groot is co-chair of the firm's Emerging Companies and Venture Capital Group and a member of the executive committee of the firm’s Cleantech Group. He also serves on the executive committee and board of directors of CONNECT.